Although GLP-1 medications have been around for decades as diabetes drugs, they have only recently been approved for weight loss by the Federal Drug Administration (FDA), and thats what has led to a significant increase in popularity and a rise in microdosing them
Your own goals and readiness for maintenance
Kastenmller are co-inventors (through Duke University/Helmholtz Zentrum Mnchen) on patents on applications of metabolomics in diseases of the central nervous system and hold equity in Chymia LLC and IP in PsyProtix and Atai that are exploring the potential for therapeutic applications targeting mitochondrial metabolism in treatment-resistant depression
Bring the laboratory requisition and required identification
doi:10.2174/1381612826666200424180139 Park JM, Lee HJ, Sikiric P, Hahm KB
In order to monitor the intracellular translocation of agonists, as well as GLP-1Rs, we used fluorescently labeled exendin-4, exendin-phe1, and exendin-asp3 conjugates, with fluorescein isothiocyanate (FITC) at position K12, which we previously found useful for labeling GLP-1R 28